A detailed history of Cibc Private Wealth Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 4,991 shares of MRNA stock, worth $213,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,991
Previous 6,848 27.12%
Holding current value
$213,365
Previous $729,000 18.79%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$101.21 - $166.61 $187,946 - $309,394
-1,857 Reduced 27.12%
4,991 $592,000
Q1 2024

May 10, 2024

BUY
$85.37 - $115.44 $339,772 - $459,451
3,980 Added 138.77%
6,848 $729,000
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $199,354 - $299,505
2,868 New
2,868 $285,000
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $322,684 - $423,763
3,347 New
3,347 $345,000
Q2 2023

Nov 21, 2023

BUY
$118.5 - $160.53 $235,104 - $318,491
1,984 New
1,984 $241,000
Q2 2023

Aug 10, 2023

SELL
$118.5 - $160.53 $40,882 - $55,382
-345 Reduced 14.81%
1,984 $241,000
Q1 2023

Nov 21, 2023

BUY
$135.66 - $197.02 $315,952 - $458,859
2,329 New
2,329 $357,000
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $1.12 Million - $1.62 Million
-8,244 Reduced 77.97%
2,329 $357,000
Q4 2022

Jun 01, 2023

BUY
$118.38 - $210.04 $1.25 Million - $2.22 Million
10,573 New
10,573 $1.9 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $1.01 Million - $1.78 Million
8,496 Added 409.05%
10,573 $1.9 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $16,529 - $27,185
-140 Reduced 6.31%
2,077 $246,000
Q2 2022

Aug 03, 2022

SELL
$117.13 - $176.59 $636,133 - $959,060
-5,431 Reduced 71.01%
2,217 $316,000
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $681,998 - $1.27 Million
5,393 Added 239.16%
7,648 $1.32 Million
Q4 2021

Feb 08, 2022

SELL
$225.82 - $368.51 $235,304 - $383,987
-1,042 Reduced 31.6%
2,255 $573,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $143,125 - $312,483
645 Added 24.32%
3,297 $1.27 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $10,392 - $18,798
80 Added 3.11%
2,652 $623,000
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $3,712 - $6,323
34 Added 1.34%
2,572 $337,000
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $166,848 - $431,104
2,538 New
2,538 $265,000
Q2 2020

Aug 13, 2020

SELL
$29.67 - $80.0 $705,048 - $1.9 Million
-23,763 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $422,506 - $750,435
23,763 New
23,763 $712,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.